Candidiasis

FDA Approves Additional Indication for Astellas' MYCAMINE(R)

... was approved in 2005 for the treatment of patients with esophageal candidiasis and is the only echinocandin approved for the prophylaxis of Candida ... Peritonitis and Abscesses; for the treatment of patients with Esophageal candidiasis and the prophylaxis of Candida Infections in patients undergoing ...

Breast Cancer Drug May Beat Fungal Infection

... another way to help these critically ill patients." More information The U.S. Centers for Disease Control and Prevention has more about candidiasis . -- Kevin McKeever SOURCE: University of Rochester Medical Center, news release, July 20, ...

Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease

... infection should be initiated prior to CIMZIA use. Invasive fungal infections, including histoplasmosis , coccidioidomycosis , candidiasis , aspergillosis , blastomycosis , and pneumocystosis . Patients with histoplasmosis or other invasive fungal infections may present ...

Strativa Pharmaceuticals Provides Product Pipeline Update

... Rx a total of $3.5 million for the completion of certain milestones. Loramyc (R) (miconazole Lauriad) for the treatment of oropharyngeal candidiasis (OPC) After preliminary review, the FDA has informed BioAlliance Pharma, Strativa's development partner, that the agency did not accept its NDA ...

Vusion Baby Bottom Line Report: Many Moms Don't Know that Their Babies' Irritated Skin Could Indicate a Severe Diaper Rash that Requires Medical Treatment

... area by a baby's stool. A microscopic evaluation is needed to determine if a baby is suffering from Diaper Dermatitis complicated by documented candidiasis (DDCC). Treating DDCC, along with a regimen of cleansing and frequent diaper changes, may require the use of a prescription skin medication. ...

New IDSA Clinical Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients

... with prolonged neutropenia from chemotherapy. In October 2006, the FDA approved NOXAFIL Oral Suspension for the treatment of oropharyngeal candidiasis (OPC), including infections refractory to itraconazole and/or fluconazole. OPC is a fungal infection of the mouth and throat caused by the yeast ...

Anti-Retroviral Therapies Associated with Reduced Infections in HIV-Infected Children

... herpes zoster (IR, 1.11), dermatophyte infections (IR, 0.88), and oral candidiasis (IR, 0.93). Infection rates were significantly lower than those reported ... pneumonia (IR, 11.1), bacteremia (IR, 3.3), herpes zoster (IR, 2.9), oral candidiasis (IR, 1.2) and tuberculosis (IR, 0.2). “Despite these current ...

Fight against Fungus - A new ray of hope

... a disease called candidiasis. Patients who are most vulnerable to candidiasis are those who are HIV-positive, those who have received organ transplants ... hospital set-up. The drug, which has not yet been approved for use in candidiasis patients, due to its high cost will be reserved for the sickest kinds of ...

New Anti Fungal Drug Eraxis as Good as the Older Medicine

... but they can be life-threatening for people who are already ill and for babies who are born pre-term and tiny. The first compound used to treat candidiasis (yeast infection) was amphotericin B, which was effective but was limited by side effects. Over the years, less toxic alternatives were developed ...

Cancer patients can now take once daily medication for infections

... and neck cancer who are undergoing radiation// therapy can now take once a day medication to fight oropharyngeal candidiasis. Oropharyngeal candidiasis is a fungal infection in the mouth caused by the yeast Candida. This condition is also called thrush. The symptoms of the disease are the formation ...

More>>

Candidiasis in Medical Technology

RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China

... will Fill Void in the Local Treatment of Oral candidiasis in Immunosuppressed Patients in China ... create issues in patients." About Oral candidiasis Oral candidiasis, which is sometimes called ... mucosa of the mouth may appear inflamed. Oral candidiasis often occurs in immunocompromised people such as ...

Strativa Pharmaceuticals Provides Product Pipeline Update

... Rx a total of $3.5 million for the completion of certain milestones. Loramyc (R) (miconazole Lauriad) for the treatment of oropharyngeal candidiasis (OPC) After preliminary review, the FDA has informed BioAlliance Pharma, Strativa's development partner, that the agency did not accept its NDA ...

Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis

... top-line results for a Phase III study of Loramyc(R) (miconazole Lauriad(R)) mucoadhesive buccal tablets, in the treatment of oropharyngeal candidiasis (OPC). Top line data show that Loramyc(R) achieved its primary endpoint of noninferiority to Mycelex(R) Troche (clotrimazole)* in the ...

Data on Telavancin and Micafungin Hold Promise of New Therapeutic Options in Fight Against Serious Infectious Disease

... showed that in paediatric patients with invasive candidiasis or candidaemia, micafungin was as effective as ... in the US for the treatment of oesophageal candidiasis and for the prophylaxis of fungal infections ... large, phase III trial in patients with invasive candidiasis and candidaemia. ECCMID, Munich. Abstract number ...

Pacgen Announces Positive Results from Phase I/II Trial of Novel Antifungal Drug

... PAC-113 dose and formulation. "For many immunocompromised patients oral candidiasis can be severe, impacting their ability to get appropriate nutrition. ... for asthma or rhinitis are also at risk. Oropharyngeal candidiasis infection can cause great discomfort, and if not treated, can spread from ...

Scientific Results Presented At ECCMID Demonstrate Well- Differentiated Profile of Basilea's Two Phase III Anti- infective Compounds

... isavuconazole for the potential treatment of invasive fungal infections is in phase III testing in a global trial program in patients with invasive candidiasis including candidemia and patients with proven or probable aspergillosis. New microbiological surveillance data relevant for the treatment of ...

Candidiasis in Medical Dictionary

Candidiasis

... candidiasis Related Category: Pathology ... s caused by the fungus Candida albicans. candidiasis WHAT YOU SHOULD KNOW Also known as a yeast infection , vagina l candidiasis (can-dih-DYE-ah-sis) is a very common infection ...

Cutaneous

... on the surface of the skin . Cutaneous candidiasis Definition: Cutaneous candidiasis is an infection of the skin caused by the ... and redness in the area. Cutaneous candidiasis ( Yeast Infection of the Skin and Mucous ...

Oral candidiasis

... Oral candidiasis , or thrush , is a fungal infection of the ... tissue red and raw. In adults, oral candidiasis can be cured. However, the long-term outlook is ... product for prophylaxis and treatment of oral candidiasis in immunocompromised patients. Currently in ...

Thrush

... s of the mouth and tongue . Alternative Names: candidiasis - oral; Oral thrush Causes, incidence , ... tongue , mouth, and throat. Thrush Oral candidiasis , or thrush , is a fungal infection of the ... acidophilus may also be useful in preventing candidiasis ( thrush ), including in the vagina . Common ...

Vaginal yeast infection

... that is white and curd-like. Vulvovaginal candidiasis (VVC), sometimes referred to as candida l ... also has been called "vulvovaginal candidiasis ," " candida l vaginitis ," "monilial infection ... the treatment of vaginal yeast infection s ( candidiasis ) and associated vulva r itching and ...

Yeast

... Should You Worry? More on Yeast Infection candidiasis - infection of the mucous membrane s caused ... the fungus Candida albicans. Other terms for candidiasis are yeast infection , moniliasis and ... infection , and up to 45% have two or more. candidiasis , sometimes called moniliasis or a yeast ...

Yeast Infections

... the treatment of vaginal yeast infection s ( candidiasis ) and associated vulva r itching and ... numbers when this balance is disturbed to cause candidiasis of the intestinal tract, or yeast infections ... . Also called Monilia albicans. vagina l candidiasis (can-dih-DYE-ah-sis) is a very common infection ...

Yeast infection

... : Should You Worry? More on Yeast Infection candidiasis - infection of the mucous membrane s caused ... the fungus Candida albicans. Other terms for candidiasis are yeast infection , moniliasis and thrush ... may help reduce your risk. Yeast Infection ( candidiasis ) What is a yeast infection ? A yeast infection ...

Fungus

... or they can be opportunistic pathogen s (such as aspergillosis , candidiasis , ... Fungus or Fungi Multi media from HONselect: Fungi Fungus A ... , histoplasmosis , blasto mycosis , cryptococcosis, sporotrichosis, and candidiasis . Thrush is caused by infection with the Candida organ ism, a ...

Infection

... s are bacterial vaginosis, trichomoniasis , and vulvovaginal candidiasis . Infection , urinary tract ( UTI ): An infection in the urinary ... papion; papist; Papovaviridae; papovaviridae infection s ; ... candidiasis A common fungal infection . Carcinogen A substance that causes ...

More>>

Candidiasis in Biological News

Montreal researchers identify defects of immune cells

... (HIV). These findings, revealed using a model of candidiasis in transgenic mice expressing HIV developed by ... and well-being. Of added concern, treatment of candidiasis in these patients is often complicated by strains ... primarily determine the susceptibility to oral candidiasis in transgenic mice expressing HIV-1 and ...

Candidiasis in Biological Technology

FDA Clears Caspofungin (Cancidas(R)) Susceptibility Testing for TREK Sensititre(R) YeastOne(R) in Vitro Diagnostics (IVD) Product Line

... antifungal agents, caspofungin, is FDA-cleared for treatment of candidiasis in adults and pediatric patients. candidiasis is a fungal infection that can be life-threatening if it becomes systemic. ...

TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm

... Germany, Italy, Benelux and the Nordic area where it is in the process of launching its first product, Loramyc(R), for the treatment of oropharyngeal candidiasis in immune-compromised patients. For more information about SpePharm, please visit the web site at http://www.spepharm.com . Contact ...

Sagent Pharmaceuticals Launches Cefazolin for Injection, USP

... can be effective in reducing the incidence of certain surgical infections. The most common adverse effects may include mild nausea, diarrhea, oral candidiasis and pain or tenderness at the injection site. Less common adverse effects include vomiting, and rarely, pseudomembranous colitis. About Sagent ...

Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine

... The company has launched its first portfolio product (Loramyc(R)) in France, which is currently in Phase III clinical development in oropharyngeal candidiasis in the USA. In addition, two other innovative products are currently in phase III clinical trials: acyclovir Lauriad(R) in oral herpes (based on the ...

GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry

... In addition, Anacor has a portfolio of other topical product candidates in development for the treatment of psoriasis, gingivitis, acne, vaginal candidiasis and tinea pedis. About GlaxoSmithKline GlaxoSmithKline, one of the world's leading research-based pharmaceutical and healthcare companies, is ...

Anacor Files Registration Statement for Initial Public Offering

... In addition, Anacor has a portfolio of other topical product candidates in development for the treatment of psoriasis, gingivitis, acne, vaginal candidiasis and tinea pedis. ...